Research progress on M2-tumor-associated macrophages in signaling pathways of colorectal cancer_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

JIA Xiahe ¹ , WANG Yitong ² , WANG Ercong ¹ , CHEN Tao ¹ , YAN Junqian ¹ ,  JIANG Lei ³

1. The First Clinical College of Medicine, Lanzhou University, Lanzhou 730000, P. R. China;
2. School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, P. R. China;
3. Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou 730000, P. R. China;

Corresponding?author：

JIANG Lei, Email: jiangyjsggyx@163.com

Keywords：

tumor-associated macrophages; tumor microenvironment; signaling pathways; colorectal cancer

DOI：

10.7507/1007-9424.202604093

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To summarize the key roles of M2-tumor-associated macrophages (M2-TAMs) in the progression of colorectal cancer (CRC) through the regulation of signaling pathways, and to discuss corresponding potential intervention strategies. Method Based on a systematic review of published literature, this article comprehensively analyzes the key roles of M2-TAMs in the signaling pathways governing CRC progression and summarizes the upstream pathways regulating M2-TAMs recruitment and polarization, as well as the core downstream effector networks driving their pro-tumorigenic functions. Results Among the upstream pathways of M2-TAMs, cytokine/chemokine pathways (CCL2/CCR2, CSF-1R, IL-6/JAK/STAT3, and CXCL12-CXCR4) mediate chemotactic recruitment and pro-tumor polarization, whereas metabolic sensing pathways (lactate and succinate) shape the pro-tumor phenotype of TAMs through metabolic reprogramming. The downstream effector pathways exhibit a clear functional division: the EGF/EGFR/PI3K/Akt/mTOR axis primarily mediates proliferation and survival, whereas the TGF-β/Smad/non-Smad, Wnt/β-catenin, and Notch/Jagged1 pathways synergistically drive invasion and metastasis. These pathways coordinately facilitate the pro-tumorigenic effects of M2-TAMs. Based on the above mechanisms, intervention strategies targeting key nodes such as CSF-1R, CCR2, and CXCR4 provide promising therapeutic options for CRC. Conclusions This review elucidates the key regulatory roles of M2-TAMs in CRC signaling networks. Based on these findings, multi-pathway combinatorial blockade and precise modulation of TAMs subpopulations deserve further investigation. However, TAMs plasticity, signal context-dependency, and microenvironment heterogeneity remain core bottlenecks limiting clinical translation. Future efforts should focus on the development of novel therapeutic modalities and the design and validation of combination regimens to promote the clinical translation of TAMs-targeted therapeutic strategies.

Citation： JIA Xiahe, WANG Yitong, WANG Ercong, CHEN Tao, YAN Junqian, JIANG Lei. Research progress on M2-tumor-associated macrophages in signaling pathways of colorectal cancer. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2026, 33(7): 977-984. doi: 10.7507/1007-9424.202604093 Copy

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.	Lian G, Chen S, Ouyang M, et al. Colon cancer cell secretes EGF to promote M2 polarization of TAM through EGFR/PI3K/AKT/mTOR pathway. Technol Cancer Res Treat, 2019, 18: 1533033819849068. doi: 10.1177/1533033819849068.
33.	Guo Y, Cui J, Liang X, et al. Pancreatic cancer stem cell-derived exosomal miR-210 mediates macrophage M2 polarization and promotes gemcitabine resistance by targeting FGFRL1. Int Immunopharmacol, 2024, 127: 111407. doi: 10.1016/j.intimp.2023.111407.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.	Han J, Liang W, Li K. Unveiling the tumor microenvironment in colorectal cancer therapeutic resistance. Front Cell Dev Biol, 2026, 13: 1753180. doi: 10.3389/fcell.2025.1753180.Han J, Liang W, Li K. Unveiling the tumor microenvironment in colorectal cancer therapeutic resistance. Front Cell Dev Biol, 2026, 13: 1753180. doi: 10.3389/fcell.2025.1753180.
51.	Cheng D, Ge K, Yao X, et al. Tumor-associated macrophages mediate resistance of EGFR-TKIs in non-small cell lung cancer: mechanisms and prospects. Front Immunol, 2023, 14: 1209947. doi: 10.3389/fimmu.2023.1209947.Cheng D, Ge K, Yao X, et al. Tumor-associated macrophages mediate resistance of EGFR-TKIs in non-small cell lung cancer: mechanisms and prospects. Front Immunol, 2023, 14: 1209947. doi: 10.3389/fimmu.2023.1209947.
52.
53.
54.

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32. Lian G, Chen S, Ouyang M, et al. Colon cancer cell secretes EGF to promote M2 polarization of TAM through EGFR/PI3K/AKT/mTOR pathway. Technol Cancer Res Treat, 2019, 18: 1533033819849068. doi: 10.1177/1533033819849068.
33. Guo Y, Cui J, Liang X, et al. Pancreatic cancer stem cell-derived exosomal miR-210 mediates macrophage M2 polarization and promotes gemcitabine resistance by targeting FGFRL1. Int Immunopharmacol, 2024, 127: 111407. doi: 10.1016/j.intimp.2023.111407.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50. Han J, Liang W, Li K. Unveiling the tumor microenvironment in colorectal cancer therapeutic resistance. Front Cell Dev Biol, 2026, 13: 1753180. doi: 10.3389/fcell.2025.1753180.Han J, Liang W, Li K. Unveiling the tumor microenvironment in colorectal cancer therapeutic resistance. Front Cell Dev Biol, 2026, 13: 1753180. doi: 10.3389/fcell.2025.1753180.
51. Cheng D, Ge K, Yao X, et al. Tumor-associated macrophages mediate resistance of EGFR-TKIs in non-small cell lung cancer: mechanisms and prospects. Front Immunol, 2023, 14: 1209947. doi: 10.3389/fimmu.2023.1209947.Cheng D, Ge K, Yao X, et al. Tumor-associated macrophages mediate resistance of EGFR-TKIs in non-small cell lung cancer: mechanisms and prospects. Front Immunol, 2023, 14: 1209947. doi: 10.3389/fimmu.2023.1209947.
52.
53.
54.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Research progress on M2-tumor-associated macrophages in signaling pathways of colorectal cancer

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content